CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 92 enrolled
Drug / intervention
Glucomannan +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01151878
NCT01151878Phase 3Completed
CompareCT.gov

Glucomannan in Treating Childhood Functional Constipation: a Randomized, Double-blind, Placebo-controlled Trial.

Medical University of Warsaw·interventional·Posted Jun 29, 2010·Updated Feb 24, 2017

In Brief

A Phase 3 clinical trial evaluating Glucomannan and maltodextrin for Functional Constipation. Completed, enrolled 92 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether administration of glucomannan (dietary fiber) is effective in treating functional constipation in children.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFunctional Constipation
CountriesPoland
Collaborators--

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 29, 2010
Enrollment StartApr 1, 2009
Primary CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 16.0 years ago

Interventions

Glucomannandietary

1.26 g per sachet; 2 sachets per day for 4 weeks.

maltodextrindietary

prepared in sachets (1.3g); 2 sachets per day for 4 weeks